In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 31 for your search:
Drug:  fluorine F 18 fluorothymidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: FLT101, NCT00847509
2.

Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P020907, NCT00236275
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSI3926g, ML20773, NCT00453362
4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573917, NCCTG-N057K, N057K, NCT00553150
5.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 9420-04, 2004-033, NCT00624728
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01438, 03-032, CDR0000304738, MSKCC-03032, NCI-5917, 5917, NCT00062374
7.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-005393-73, 06159, NCT00568841
8.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 200801758, 1R21CA130281, NCT00721799
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC057M, P30CA015083, 08-002166, NCI-2009-01193, MAYO-MC057M, MAYO-08-002166, NCT00757549
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 35 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0000-139, 2009_692, NCT01015131
11.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02899, NA_00017885, N01CM00070, NCT00963807
12.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 200906786, NCT01075412
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA191-011, NCT01225172
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00266, ACRIN 6688, HM11081, CDR0000689109, NCT00572728
15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120199, 12-C-0199, NCT01679743
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00039, 03-082, U01CA062490, DFCI-03082, NCI-6052, 6052, NCT00070239
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00245, CO 06902, CDR0000552705, H-2007-0039, U01CA062491, WCCC-CO-06902, 7898, NCT00499135
18.

Phase: Phase I
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: D0008186, NCT00553748
19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 089025, NCT00859118
20.

Phase: Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0658, NCT01143779
21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00764, CO 09904, CDR0000688559, WCCC-CO-09904, 8477, U01CA070095, U01CA062491, NCT01243359
22.

Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000455011, UW-6230, NCI-7223, 6230, 7223, NCT00276770
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: FLT01 - UC-0140/0505, FRE-FNCLCC-FLT-01/0505, EU-20754, 2005-005166-37, FLT 01/0505, NCT00534274
24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI21897, NCT00694096
25.

Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-142, NCT00832598
1   
New Search